Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Aligns New Pharmaceutical Inspectorate Into Six Divisions

Executive Summary

US FDA’s structure for its new pharmaceutical inspectorate, part of the massive reorganization of the Office of Regulatory Affairs, includes four domestic divisions, a fifth handling foreign inspections and the sixth handling program functions. New staff directory could prove valuable to pharmaceutical companies learning to interact with a very different field organization.


Related Content

FDA Accelerates Inspection Process With New Concept Of Operations
US FDA's China Staff Increase Takes Hold As Gottlieb Boosts Border Security
User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases
US FDA Urged To Rethink Warning Letters To Avoid ‘Collateral Damage’
Manufacturers' Data Integrity Problems Remain FDA Investigators' Focus
US FDA's Program Alignment: Where Should Form-483 Responses Go After May 15?
FDA Drugs Field Staff May Be Based In Four Offices After Realignment





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts